Optimi Health Granted Amendment to Dealer’s Licence by Health Canada to Supply Special Access Program
VANCOUVER, British Columbia, September 7, 2023 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly announced today that Health Canada has approved an amendment to the Company’s Dealers Licence. The
September 7, 2023
